Artivion (AORT) EVP Lance Berry gets stock award, sells shares for taxes

Rhea-AI Filing Summary

Artivion, Inc. executive Lance A. Berry reported equity compensation activity and a related tax sale of shares. He acquired 40,874 shares of common stock on a grant or award basis at a price of $0.0000 per share on March 2, 2026, connected to performance stock units granted on February 28, 2025. One third of these units were issued on March 2, 2026, with the remaining thirds scheduled to be eligible to vest on February 28, 2027 and February 28, 2028, assuming continued employment.

On March 3, 2026, 6,316 shares of common stock were sold in an open-market transaction at an average price of $37.7756 per share to cover tax withholding obligations arising from the vesting of these performance stock units. The filing states this “sell to cover” transaction was undertaken to satisfy tax obligations and does not represent a discretionary trade. Following these transactions, Berry directly held 210,827 shares of Artivion common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berry Lance A

(Last) (First) (Middle)

1655 ROBERTS BLVD NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, COO, CFO & Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		40,874(1)	A	$0	217,143	D
Common Stock	03/03/2026		S		6,316(2)	D	$37.7756	210,827	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Remarks:

	/s/ Lance A. Berry	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Artivion (AORT) executive Lance A. Berry report?

Lance A. Berry reported receiving 40,874 Artivion common shares as a grant or award on March 2, 2026, and selling 6,316 shares on March 3, 2026. The sale was specifically to cover tax withholding from vested performance stock units.

Was the March 3, 2026 sale by Artivion (AORT) executive Lance A. Berry discretionary?

The March 3, 2026 sale of 6,316 Artivion shares was not discretionary. It was executed as a “sell to cover” transaction to pay tax withholding obligations triggered by the vesting of performance stock units granted in February 2025.

What is the vesting schedule for Lance A. Berry’s Artivion (AORT) performance stock units?

The performance stock units were granted on February 28, 2025. One third were issued on March 2, 2026, with additional one-third portions eligible to vest on February 28, 2027 and February 28, 2028, contingent on continued employment at each vesting date.

How many Artivion (AORT) shares does Lance A. Berry hold after these Form 4 transactions?

After the reported grant and tax-related sale, Lance A. Berry directly holds 210,827 shares of Artivion common stock. This figure comes from the Form 4’s post-transaction ownership line for his March 3, 2026 open-market sale entry.

At what price were Artivion (AORT) shares sold in Lance A. Berry’s tax-withholding sale?

The 6,316 Artivion shares sold on March 3, 2026 to cover tax withholding were executed at an average price of $37.7756 per share. This sale was tied to the vesting of previously granted performance stock units.

What role does Lance A. Berry hold at Artivion (AORT) according to the Form 4?

According to the Form 4, Lance A. Berry serves as Executive Vice President, Chief Operating Officer, Chief Financial Officer, and Treasurer of Artivion, Inc. He is listed as an officer and not as a director or ten-percent owner.